Cognex (CGNX) Financials

$30.72 +1.00 (+3.36%)

Closing price 04:00 PM Eastern

Extended Trading

$30.74 +0.02 (+0.05%)

As of 07:36 PM Eastern

Annual Income Statements for Cognex

This table shows Cognex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	106	113	216	280	176	204	219	177	144	187
Consolidated Net Income / (Loss)	106	113	216	280	176	204	219	177	144	187
Net Income / (Loss) Continuing Operations	106	113	216	280	176	204	219	177	144	108
Total Pre-Tax Income	131	135	251	319	187	163	235	266	162	127
Total Operating Income	115	131	246	315	171	143	221	259	154	122
Total Gross Profit	626	601	722	760	605	536	600	579	398	348
Total Revenue	915	838	1,006	1,037	811	726	806	766	530	451
Operating Revenue	915	838	1,006	1,037	811	726	806	766	530	451
Total Cost of Revenue	289	236	284	277	206	190	206	187	131	103
Operating Cost of Revenue	289	236	284	277	206	190	206	187	131	103
Total Operating Expenses	511	471	476	445	434	393	379	320	244	226
Selling, General & Admin Expense	371	339	312	309	268	274	263	221	166	157
Research & Development Expense	140	139	141	135	131	119	116	99	78	70
Other Operating Expenses / (Income)	0.00	-8.00	21	0.00	-	-	-	-	-	-
Restructuring Charge	0.00	0.00	1.66	0.00	16	0.00	0.00	-	-	-
Total Other Income / (Expense), net	16	4.65	4.47	3.80	16	20	13	7.60	8.01	5.44
Interest & Investment Income	14	14	6.72	6.66	13	20	15	9.54	7.04	3.67
Other Income / (Expense), net	2.45	-9.45	-2.25	-2.86	3.39	0.70	-1.28	-1.94	0.97	1.77
Income Tax Expense	25	22	35	39	11	-41	15	90	18	19
Basic Earnings per Share	$0.62	$0.66	$1.24	$1.59	$1.02	$1.19	$1.27	$1.02	$0.84	$1.08
Weighted Average Basic Shares Outstanding	171.44M	172.25M	173.41M	176.46M	173.49M	171.19M	172.33M	173.29M	170.68M	172.59M
Diluted Earnings per Share	$0.62	$0.65	$1.23	$1.56	$1.00	$1.16	$1.24	$0.98	$0.83	$1.06
Weighted Average Diluted Shares Outstanding	172.61M	173.40M	174.87M	179.92M	176.59M	175.27M	177.41M	179.55M	174.14M	175.98M
Weighted Average Basic & Diluted Shares Outstanding	169.87M	343.27M	345.07M	347.83M	352.06M	172.61M	172.70M	173.20M	170M	86.20M
Cash Dividends to Common per Share	$0.31	$0.29	$0.27	$0.25	$2.23	$0.21	$0.19	$0.17	$0.15	$0.11

This table shows Cognex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	10/2/2022
Net Income / (Loss) Attributable to Common Shareholders	24	28	30	36	12	11	19	57	26	55	34
Consolidated Net Income / (Loss)	24	28	30	36	12	11	19	57	26	55	34
Net Income / (Loss) Continuing Operations	24	28	30	36	12	11	19	57	26	55	34
Total Pre-Tax Income	28	36	37	42	18	14	27	68	26	59	39
Total Operating Income	26	31	32	38	14	13	31	65	22	54	40
Total Gross Profit	144	158	159	167	142	135	143	180	144	170	152
Total Revenue	216	230	235	239	211	197	197	243	201	239	210
Operating Revenue	216	230	235	239	211	197	197	243	201	239	210
Total Cost of Revenue	72	72	75	73	69	62	54	63	57	70	57
Operating Cost of Revenue	72	72	75	73	69	62	54	63	57	70	57
Total Operating Expenses	118	127	128	128	128	122	112	115	122	115	112
Selling, General & Admin Expense	84	94	93	93	91	90	82	83	83	76	75
Research & Development Expense	35	33	35	35	37	35	33	34	39	37	34
Total Other Income / (Expense), net	1.71	4.96	4.99	3.11	3.36	1.63	-3.64	2.60	4.05	4.89	-0.68
Interest & Investment Income	3.99	4.17	3.56	3.12	3.12	1.52	4.89	4.10	3.59	2.33	1.42
Other Income / (Expense), net	-2.28	0.79	1.43	-0.01	0.24	0.11	-8.53	-1.49	0.47	2.57	-2.09
Income Tax Expense	4.20	7.45	6.96	5.36	5.54	3.13	8.09	10	0.60	3.92	5.37
Basic Earnings per Share	$0.14	$0.17	$0.17	$0.21	$0.07	$0.07	$0.11	$0.33	$0.15	$0.31	$0.20
Weighted Average Basic Shares Outstanding	169.27M	171.44M	171.52M	171.57M	171.69M	172.25M	172.17M	172.43M	172.62M	173.41M	173.26M
Diluted Earnings per Share	$0.14	$0.17	$0.17	$0.21	$0.07	$0.06	$0.11	$0.33	$0.15	$0.32	$0.19
Weighted Average Diluted Shares Outstanding	170.39M	172.61M	172.75M	172.73M	172.59M	173.40M	173.35M	173.62M	173.90M	174.87M	174.33M
Weighted Average Basic & Diluted Shares Outstanding	167.86M	169.87M	171.52M	171.50M	171.66M	343.27M	172.14M	172.29M	172.60M	345.07M	172.93M
Cash Dividends to Common per Share	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.07	$0.07	$0.07	$0.07	$0.07

This table details how cash moves in and out of Cognex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-17	21	-4.79	-83	98	63	2.72	27	28	-3.72
Net Cash From Operating Activities	149	113	243	314	242	253	223	224	182	128
Net Cash From Continuing Operating Activities	149	113	243	314	242	253	223	224	182	128
Net Income / (Loss) Continuing Operations	106	113	216	280	176	204	219	177	144	187
Consolidated Net Income / (Loss)	106	113	216	280	176	204	219	177	144	187
Depreciation Expense	21	17	16	17	22	22	18	14	12	9.87
Amortization Expense	12	6.36	8.24	8.55	5.64	2.76	3.18	3.51	3.77	4.94
Non-Cash Adjustments To Reconcile Net Income	49	63	106	48	72	57	43	32	19	-58
Changes in Operating Assets and Liabilities, net	-39	-87	-103	-39	-34	-32	-60	-1.17	3.63	-15
Net Cash From Investing Activities	-39	32	-4.45	-253	169	-157	-11	-106	-122	-11
Net Cash From Continuing Investing Activities	-39	32	-4.45	-253	169	-157	-11	-106	-122	-11
Purchase of Property, Plant & Equipment	-15	-23	-20	-15	-13	-22	-37	-29	-13	-18
Acquisitions	-1.44	-257	-5.05	0.00	1.00	-167	-4.27	-24	-14	-11
Purchase of Investments	-851	-184	-234	-668	-923	-1,032	-782	-637	-752	-687
Sale and/or Maturity of Investments	828	496	254	431	1,105	1,063	813	584	657	601
Net Cash From Financing Activities	-118	-126	-240	-142	-317	-32	-210	-100	-29	-117
Net Cash From Continuing Financing Activities	-118	-126	-240	-142	-317	-32	-210	-100	-29	-117
Repurchase of Common Equity	-67	-80	-204	-162	-51	-62	-204	-124	-47	-126
Payment of Dividends	-52	-49	-46	-43	-391	-35	-32	-29	-25	-18
Issuance of Common Equity	0.99	3.27	9.86	63	126	65	27	55	43	28
Effect of Exchange Rate Changes	-8.25	1.70	-3.37	-2.82	2.67	-0.52	-	8.29	-3.35	-4.67

This table details how cash moves in and out of Cognex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	10/2/2022
Net Change in Cash & Equivalents	-42	-11	20	38	-64	-193	218	13	-17	-85	89
Net Cash From Operating Activities	41	51	56	28	14	14	41	30	28	66	84
Net Cash From Continuing Operating Activities	41	51	56	28	14	14	41	30	28	66	84
Net Income / (Loss) Continuing Operations	24	28	30	36	12	11	19	57	26	55	34
Consolidated Net Income / (Loss)	24	28	30	36	12	11	19	57	26	55	34
Depreciation Expense	5.31	5.37	5.43	5.19	5.28	4.71	4.38	4.19	3.99	4.17	4.06
Amortization Expense	2.47	2.36	3.26	2.98	3.12	2.58	0.89	1.24	1.64	1.80	2.07
Non-Cash Adjustments To Reconcile Net Income	10	6.49	13	15	15	19	14	13	17	14	16
Changes in Operating Assets and Liabilities, net	-1.29	8.84	4.49	-31	-21	-23	2.94	-46	-21	-9.14	27
Net Cash From Investing Activities	33	2.23	-27	35	-49	-179	200	17	-5.79	-127	47
Net Cash From Continuing Investing Activities	33	2.23	-27	35	-49	-179	200	17	-5.79	-127	47
Purchase of Property, Plant & Equipment	-2.50	-2.07	-4.40	-4.51	-4.06	-7.02	-5.86	-4.70	-5.51	-4.06	-4.35
Acquisitions	0.00	-	-	-0.45	-0.99	-257	-	-	0.00	-	-
Purchase of Investments	-113	-202	-379	-36	-234	-9.73	-80	-48	-46	-156	-
Sale and/or Maturity of Investments	149	206	356	76	190	94	286	70	46	38	51
Net Cash From Financing Activities	-118	-56	-15	-22	-25	-33	-22	-31	-39	-32	-36
Net Cash From Continuing Financing Activities	-118	-56	-15	-22	-25	-33	-22	-31	-39	-32	-36
Repurchase of Common Equity	-102	-43	-3.96	-11	-9.34	-20	-10	-25	-24	-26	-24
Payment of Dividends	-14	-14	-13	-13	-13	-13	-12	-12	-12	-12	-11
Issuance of Common Equity	-2.59	1.20	1.67	0.99	-2.86	-0.01	0.62	5.71	-3.06	5.64	-0.19
Effect of Exchange Rate Changes	2.43	-8.86	6.75	-2.82	-3.33	5.19	-1.38	-2.47	0.36	8.45	-5.95

This table presents Cognex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	1,993	2,018	1,958	2,004	1,801	1,886	1,290	1,288	1,039	888
Total Current Assets	613	679	718	640	602	607	780	630	526	444
Cash & Equivalents	186	203	181	186	269	171	108	107	80	52
Short-Term Investments	60	129	219	137	103	240	427	298	341	296
Accounts Receivable	146	117	128	134	131	108	127	127	58	43
Inventories, net	158	162	122	113	61	60	83	68	27	37
Prepaid Expenses	63	68	67	69	37	27	34	31	21	16
Plant, Property, & Equipment, net	98	106	80	78	79	89	91	78	54	53
Total Noncurrent Assets	1,281	1,233	1,161	1,286	1,120	1,189	418	580	458	390
Long-Term Investments	341	244	454	584	395	433	262	423	324	273
Goodwill	385	393	243	242	244	243	113	113	95	81
Intangible Assets	91	113	12	12	16	39	10	13	8.31	6.32
Noncurrent Deferred & Refundable Income Taxes	392	400	407	419	435	450	29	27	28	27
Other Noncurrent Operating Assets	72	82	44	30	30	23	3.93	2.49	2.32	2.61
Total Liabilities & Shareholders' Equity	1,993	2,018	1,958	2,004	1,801	1,886	1,290	1,288	1,039	888
Total Liabilities	475	513	520	574	539	530	154	192	76	62
Total Current Liabilities	169	152	188	189	132	120	91	113	66	54
Accounts Payable	38	21	27	44	16	18	16	23	9.83	7.86
Accrued Expenses	72	72	93	92	77	52	60	68	43	33
Current Deferred Revenue	25	32	41	36	21	14	9.85	9.42	8.21	12
Current Deferred & Payable Income Tax Liabilities	26	17	18	8.58	9.38	30	5.06	12	5.19	0.99
Other Current Liabilities	8.85	9.62	8.45	7.79	8.11	5.65	0.00	-	-	-
Total Noncurrent Liabilities	306	361	332	385	406	410	63	79	10	8.40
Noncurrent Deferred Revenue	0.00	18	33	43	49	51	51	67	0.00	-
Noncurrent Deferred & Payable Income Tax Liabilities	244	274	266	309	329	344	8.07	6.80	5.36	5.15
Other Noncurrent Operating Liabilities	63	69	33	33	28	15	3.87	5.90	4.87	3.25
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,518	1,505	1,438	1,430	1,262	1,356	1,135	1,096	963	826
Total Preferred & Common Equity	1,518	1,505	1,438	1,430	1,262	1,356	1,135	1,096	963	826
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Total Common Equity	1,518	1,505	1,438	1,430	1,262	1,356	1,135	1,096	963	826
Common Stock	1,091	1,038	980	915	808	640	530	462	375	311
Retained Earnings	499	513	528	563	488	753	646	669	644	567
Accumulated Other Comprehensive Income / (Loss)	-73	-45	-69	-48	-34	-37	-41	-35	-56	-52

This table presents Cognex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/30/2025	9/29/2024	6/30/2024	3/31/2024	10/1/2023	7/2/2023	4/2/2023	10/2/2022
Total Assets	1,933	2,063	2,004	2,013	1,990	1,998	1,974	1,900
Total Current Assets	578	672	681	662	847	718	722	787
Cash & Equivalents	144	197	177	139	396	177	164	266
Short-Term Investments	57	91	112	139	117	191	217	208
Accounts Receivable	164	160	161	141	132	150	147	98
Inventories, net	152	155	157	171	134	126	127	109
Prepaid Expenses	61	69	74	71	68	73	68	106
Plant, Property, & Equipment, net	96	103	103	104	83	82	81	79
Total Noncurrent Assets	1,259	1,288	1,220	1,248	1,060	1,198	1,171	1,033
Long-Term Investments	312	319	266	278	333	463	463	343
Goodwill	390	392	381	386	241	242	242	238
Intangible Assets	91	103	99	105	9.99	11	11	9.42
Noncurrent Deferred & Refundable Income Taxes	390	395	397	398	403	407	410	405
Other Noncurrent Operating Assets	75	79	78	80	73	75	44	38
Total Liabilities & Shareholders' Equity	1,933	2,063	2,004	2,013	1,990	1,998	1,974	1,900
Total Liabilities	487	496	497	524	501	518	528	511
Total Current Liabilities	184	171	169	188	170	180	214	161
Accounts Payable	43	30	23	27	23	26	27	22
Accrued Expenses	68	77	75	70	79	84	84	64
Current Deferred Revenue	40	30	41	40	40	43	58	55
Current Deferred & Payable Income Tax Liabilities	23	24	21	40	19	19	38	12
Other Current Liabilities	10	9.81	9.41	9.80	7.98	8.19	8.18	8.11
Total Noncurrent Liabilities	303	325	329	336	332	337	314	350
Noncurrent Deferred & Payable Income Tax Liabilities	239	257	263	268	253	257	264	272
Other Noncurrent Operating Liabilities	64	69	66	68	79	81	50	78
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	-	-
Total Equity & Noncontrolling Interests	1,446	1,567	1,507	1,489	1,489	1,480	1,446	1,389
Total Preferred & Common Equity	1,446	1,567	1,507	1,489	1,489	1,480	1,446	1,389
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,446	1,567	1,507	1,489	1,489	1,480	1,446	1,389
Common Stock	1,098	1,077	1,062	1,048	1,024	1,011	993	961
Retained Earnings	406	528	515	502	534	538	518	511
Accumulated Other Comprehensive Income / (Loss)	-59	-38	-70	-61	-70	-69	-64	-82

This table displays calculated financial ratios and metrics derived from Cognex's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.19%	-16.75%	-2.99%	27.88%	11.77%	-10.01%	5.25%	44.68%	17.52%	5.65%
EBITDA Growth	3.89%	-46.05%	-20.40%	67.29%	20.35%	-30.61%	-11.89%	60.78%	23.46%	-3.36%
EBIT Growth	-3.08%	-50.30%	-21.86%	79.53%	21.36%	-34.82%	-14.43%	65.72%	25.75%	-4.13%
NOPAT Growth	-15.03%	-48.34%	-23.45%	72.04%	-9.88%	-13.72%	20.41%	25.46%	32.78%	-4.19%
Net Income Growth	-6.24%	-47.46%	-22.99%	58.86%	-13.58%	-7.02%	24.08%	22.98%	-23.19%	53.99%
EPS Growth	-4.62%	-47.15%	-21.15%	56.00%	-13.79%	-6.45%	26.53%	18.07%	-23.19%	53.99%
Operating Cash Flow Growth	32.03%	-53.61%	-22.50%	29.56%	-4.31%	13.36%	-0.39%	23.20%	41.89%	-21.68%
Free Cash Flow Firm Growth	138.82%	-256.37%	-39.55%	40.97%	3,011.83%	-95.86%	12.62%	-1.73%	74.66%	-43.20%
Invested Capital Growth	0.18%	58.95%	11.75%	5.65%	-3.06%	51.14%	26.14%	23.12%	6.51%	18.81%
Revenue Q/Q Growth	3.75%	-4.86%	-0.46%	2.01%	7.11%	-3.14%	1.30%	6.22%	8.24%	2.01%
EBITDA Q/Q Growth	14.65%	-22.78%	0.05%	-2.12%	28.43%	-13.04%	-1.58%	6.33%	8.62%	-2.35%
EBIT Q/Q Growth	19.03%	-26.66%	0.24%	-2.08%	34.35%	-15.50%	-2.22%	6.50%	9.42%	-2.84%
NOPAT Q/Q Growth	18.41%	-27.30%	-0.57%	-4.06%	-3.56%	17.09%	48.87%	-24.92%	10.66%	-4.10%
Net Income Q/Q Growth	19.22%	-28.02%	0.83%	-5.35%	-5.87%	20.66%	50.08%	-25.39%	10.48%	-4.04%
EPS Q/Q Growth	21.57%	-28.57%	1.65%	-6.02%	-7.41%	17.17%	45.88%	-28.47%	10.48%	-4.04%
Operating Cash Flow Q/Q Growth	32.91%	-31.43%	4.75%	-8.12%	6.69%	-1.56%	-5.30%	4.11%	20.59%	-30.58%
Free Cash Flow Firm Q/Q Growth	138.26%	-397.31%	0.93%	-9.09%	3,440.33%	-96.70%	-15.15%	15.93%	17.33%	-42.98%
Invested Capital Q/Q Growth	-3.09%	44.41%	2.20%	2.99%	0.41%	59.09%	-0.72%	-26.14%	-8.83%	-7.27%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.43%	71.79%	71.75%	73.26%	74.55%	73.85%	74.45%	75.55%	75.25%	77.23%
EBITDA Margin	16.46%	17.30%	26.69%	32.53%	24.87%	23.10%	29.95%	35.78%	32.20%	30.65%
Operating Margin	12.58%	15.61%	24.47%	30.38%	21.03%	19.65%	27.43%	33.79%	29.10%	26.97%
EBIT Margin	12.85%	14.48%	24.25%	30.11%	21.44%	19.75%	27.27%	33.54%	29.28%	27.36%
Profit (Net Income) Margin	11.61%	13.52%	21.42%	26.99%	21.72%	28.10%	27.19%	23.07%	27.14%	41.52%
Tax Burden Percent	80.75%	83.66%	85.97%	87.76%	94.26%	125.08%	93.47%	66.32%	88.66%	147.35%
Interest Burden Percent	111.89%	111.62%	102.75%	102.13%	107.47%	113.74%	106.69%	103.71%	104.54%	102.98%
Effective Tax Rate	19.25%	16.34%	14.03%	12.24%	5.74%	-25.08%	6.53%	33.68%	11.18%	15.20%
Return on Invested Capital (ROIC)	10.00%	14.46%	38.25%	54.36%	31.99%	42.06%	68.29%	70.77%	64.92%	54.82%
ROIC Less NNEP Spread (ROIC-NNEP)	7.72%	13.91%	37.81%	53.96%	30.07%	38.96%	66.75%	70.13%	63.91%	40.65%
Return on Net Nonoperating Assets (RNNOA)	-2.97%	-6.76%	-23.22%	-33.57%	-18.53%	-25.70%	-48.64%	-53.60%	-48.85%	-30.87%
Return on Equity (ROE)	7.03%	7.69%	15.03%	20.79%	13.46%	16.37%	19.66%	17.17%	16.07%	23.95%
Cash Return on Invested Capital (CROIC)	9.82%	-31.07%	27.15%	48.86%	35.09%	1.34%	45.18%	50.05%	58.61%	37.63%
Operating Return on Assets (OROA)	5.86%	6.10%	12.32%	16.41%	9.44%	9.03%	17.06%	22.09%	16.10%	14.42%
Return on Assets (ROA)	5.29%	5.70%	10.88%	14.71%	9.56%	12.84%	17.01%	15.19%	14.92%	21.89%
Return on Common Equity (ROCE)	7.03%	7.69%	15.03%	20.79%	13.46%	16.37%	19.66%	17.17%	16.07%	23.95%
Return on Equity Simple (ROE_SIMPLE)	7.00%	7.53%	14.98%	19.57%	13.96%	15.04%	19.31%	16.13%	14.93%	22.66%
Net Operating Profit after Tax (NOPAT)	93	109	212	277	161	178	207	172	137	103
NOPAT Margin	10.16%	13.06%	21.04%	26.67%	19.82%	24.58%	25.64%	22.41%	25.84%	22.87%
Net Nonoperating Expense Percent (NNEP)	2.28%	0.54%	0.44%	0.40%	1.91%	3.10%	1.54%	0.64%	1.00%	14.17%
Return On Investment Capital (ROIC_SIMPLE)	6.12%	7.27%	14.72%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	31.57%	28.21%	28.25%	26.74%	25.45%	26.15%	25.55%	24.45%	24.75%	22.77%
SG&A Expenses to Revenue	40.56%	40.49%	31.02%	29.83%	32.99%	37.74%	32.58%	28.81%	31.37%	34.77%
R&D to Revenue	15.29%	16.64%	14.03%	13.05%	16.15%	16.46%	14.44%	12.95%	14.78%	15.49%
Operating Expenses to Revenue	55.85%	56.18%	47.28%	42.88%	53.52%	54.20%	47.02%	41.76%	46.15%	50.26%
Earnings before Interest and Taxes (EBIT)	118	121	244	312	174	143	220	257	155	123
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	151	145	269	337	202	168	242	274	170	138
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.05	4.74	5.59	9.45	10.89	6.72	5.55	9.12	5.32	3.24
Price to Tangible Book Value (P/TBV)	5.90	7.14	6.79	11.49	13.71	8.49	6.23	10.31	5.96	3.63
Price to Revenue (P/Rev)	6.73	8.52	7.99	13.03	16.95	12.55	7.82	13.04	9.68	5.94
Price to Earnings (P/E)	57.93	62.99	37.28	48.30	78.01	44.67	28.76	56.53	35.66	14.31
Dividend Yield	0.85%	0.69%	0.57%	2.94%	2.83%	0.38%	0.51%	0.00%	0.49%	0.67%
Earnings Yield	1.73%	1.59%	2.68%	2.07%	1.28%	2.24%	3.48%	1.77%	2.80%	6.99%
Enterprise Value to Invested Capital (EV/IC)	5.98	7.06	12.29	24.12	26.23	16.19	16.31	34.23	20.14	10.07
Enterprise Value to Revenue (EV/Rev)	6.08	7.83	7.14	12.16	16.00	11.39	6.83	11.96	8.27	4.56
Enterprise Value to EBITDA (EV/EBITDA)	36.96	45.25	26.74	37.37	64.34	49.30	22.80	33.43	25.68	14.88
Enterprise Value to EBIT (EV/EBIT)	47.34	54.07	29.43	40.39	74.61	57.65	25.05	35.66	28.24	16.67
Enterprise Value to NOPAT (EV/NOPAT)	59.88	59.95	33.93	45.60	80.73	46.32	26.64	53.37	32.00	19.94
Enterprise Value to Operating Cash Flow (EV/OCF)	37.32	58.06	29.50	40.15	53.53	32.62	24.65	40.84	24.05	16.01
Enterprise Value to Free Cash Flow (EV/FCFF)	60.99	0.00	47.79	50.73	73.59	1,457.96	40.28	75.47	35.44	29.05
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.39	-0.49	-0.61	-0.62	-0.62	-0.66	-0.73	-0.76	-0.76	-0.76
Leverage Ratio	1.33	1.35	1.38	1.41	1.41	1.27	1.16	1.13	1.08	1.09
Compound Leverage Factor	1.48	1.51	1.42	1.44	1.51	1.45	1.23	1.17	1.13	1.13
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	9.04	9.62	10.90	15.84	16.78	11.81	27.03	33.67	42.85	28.25
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.62	4.47	3.82	3.39	4.55	5.04	8.54	5.59	8.00	8.28
Quick Ratio	2.32	2.95	2.81	2.43	3.81	4.32	7.26	4.72	7.27	7.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	91	-235	150	249	176	5.67	137	121	124	71
Operating Cash Flow to CapEx	991.03%	489.30%	1,237.64%	2,032.13%	1,822.15%	1,164.92%	602.38%	780.15%	1,420.73%	704.01%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.42	0.51	0.55	0.44	0.46	0.63	0.66	0.55	0.53
Accounts Receivable Turnover	6.96	6.86	7.68	7.81	6.77	6.16	6.34	8.30	10.54	10.87
Inventory Turnover	1.81	1.66	2.41	3.19	3.41	2.64	2.73	3.95	4.08	3.08
Fixed Asset Turnover	8.95	9.03	12.80	13.24	9.62	8.03	9.52	11.60	9.87	9.08
Accounts Payable Turnover	9.70	9.73	7.99	9.19	12.09	11.13	10.38	11.25	14.82	8.18
Days Sales Outstanding (DSO)	52.48	53.20	47.51	46.75	53.91	59.28	57.56	43.95	34.65	33.59
Days Inventory Outstanding (DIO)	202.15	219.93	151.29	114.48	107.06	138.06	133.92	92.48	89.56	118.42
Days Payable Outstanding (DPO)	37.61	37.50	45.69	39.70	30.18	32.79	35.16	32.44	24.63	44.63
Cash Conversion Cycle (CCC)	217.02	235.63	153.11	121.53	130.78	164.55	156.33	103.99	99.57	107.38
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	930	928	584	523	495	510	338	268	217	204
Invested Capital Turnover	0.98	1.11	1.82	2.04	1.61	1.71	2.66	3.16	2.51	2.40
Increase / (Decrease) in Invested Capital	1.68	344	61	28	-16	173	70	50	13	32
Enterprise Value (EV)	5,564	6,556	7,182	12,610	12,977	8,262	5,507	9,162	4,378	2,055
Market Capitalization	6,151	7,132	8,036	13,518	13,744	9,107	6,305	9,990	5,124	2,677
Book Value per Share	$8.85	$8.74	$8.32	$8.09	$7.23	$7.93	$6.59	$12.65	$11.24	$9.73
Tangible Book Value per Share	$6.07	$5.80	$6.84	$6.65	$5.74	$6.28	$5.88	$11.19	$10.03	$8.70
Total Capital	1,518	1,505	1,438	1,430	1,262	1,356	1,135	1,096	963	826
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-587	-576	-854	-907	-767	-845	-798	-828	-745	-622
Capital Expenditures (CapEx)	15	23	20	15	13	22	37	29	13	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	198	195	130	128	97	75	153	113	40	42
Debt-free Net Working Capital (DFNWC)	444	527	530	451	469	487	689	517	461	391
Net Working Capital (NWC)	444	527	530	451	469	487	689	517	461	391
Net Nonoperating Expense (NNE)	-13	-3.89	-3.84	-3.33	-15	-26	-13	-5.04	-6.86	-84
Net Nonoperating Obligations (NNO)	-587	-576	-854	-907	-767	-845	-798	-828	-745	-622
Total Depreciation and Amortization (D&A)	33	24	25	25	28	24	22	17	15	15
Debt-free, Cash-free Net Working Capital to Revenue	21.64%	23.29%	12.91%	12.30%	11.97%	10.32%	19.03%	14.73%	7.50%	9.40%
Debt-free Net Working Capital to Revenue	48.55%	62.94%	52.68%	43.51%	57.88%	67.08%	85.44%	67.53%	86.98%	86.74%
Net Working Capital to Revenue	48.55%	62.94%	52.68%	43.51%	57.88%	67.08%	85.44%	67.53%	86.98%	86.74%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.62	$0.66	$1.24	$1.59	$1.02	$1.19	$1.27	$1.02	$0.88	$1.09
Adjusted Weighted Average Basic Shares Outstanding	171.44M	172.25M	173.41M	176.46M	173.49M	171.19M	172.33M	173.29M	170.68M	172.59M
Adjusted Diluted Earnings per Share	$0.62	$0.65	$1.23	$1.56	$1.00	$1.16	$1.24	$0.99	$0.86	$1.07
Adjusted Weighted Average Diluted Shares Outstanding	172.61M	173.40M	174.87M	179.92M	176.59M	175.27M	177.41M	179.55M	174.14M	175.98M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	169.87M	343.27M	345.07M	347.83M	352.06M	172.61M	170.83M	173.55M	172.11M	169.77M
Normalized Net Operating Profit after Tax (NOPAT)	93	109	213	277	194	100	207	172	137	103
Normalized NOPAT Margin	10.16%	13.06%	21.18%	26.67%	23.95%	13.76%	25.64%	22.41%	25.84%	22.87%
Pre Tax Income Margin	14.38%	16.16%	24.92%	30.75%	23.05%	22.46%	29.09%	34.78%	30.61%	28.18%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	49.29%	43.34%	21.31%	15.46%	221.65%	17.23%	14.53%	16.43%	17.55%	9.66%
Augmented Payout Ratio	112.47%	113.81%	116.10%	73.22%	250.61%	47.49%	107.49%	86.44%	50.36%	77.20%

This table displays calculated financial ratios and metrics derived from Cognex's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/30/2025	12/31/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	12/31/2022	10/2/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.49%	16.79%	19.01%	-1.33%	4.81%	-17.86%	-5.91%	-11.69%	-28.78%	-1.90%	-26.41%
EBITDA Growth	38.25%	95.53%	52.25%	-32.54%	-19.15%	-67.99%	-37.85%	0.11%	-69.48%	0.19%	-52.81%
EBIT Growth	64.81%	146.42%	49.22%	-39.62%	-36.16%	-77.45%	-41.70%	1.23%	-73.76%	1.05%	-56.32%
NOPAT Growth	127.90%	145.22%	19.05%	-39.38%	-55.11%	-80.38%	-37.91%	-7.21%	-67.48%	-2.83%	-55.67%
Net Income Growth	96.33%	152.44%	56.43%	-36.99%	-53.07%	-79.70%	-44.33%	-2.42%	-61.96%	3.32%	-56.93%
EPS Growth	100.00%	183.33%	54.55%	-36.36%	-53.33%	-81.25%	-42.11%	-2.94%	-60.53%	6.67%	-56.82%
Operating Cash Flow Growth	196.87%	254.73%	37.17%	-6.99%	-50.48%	-78.13%	-50.88%	-32.33%	-44.36%	20.01%	30.23%
Free Cash Flow Firm Growth	106.82%	106.80%	-483.77%	-3,046.33%	-1,880.02%	-3,032.56%	-69.48%	114.17%	6.35%	-144.01%	-146.62%
Invested Capital Growth	0.03%	0.18%	49.29%	46.83%	54.80%	58.95%	12.49%	7.66%	6.70%	11.75%	12.61%
Revenue Q/Q Growth	-5.94%	-2.15%	-1.90%	13.52%	7.18%	-0.29%	-18.67%	20.58%	-16.00%	14.22%	-23.67%
EBITDA Q/Q Growth	-19.75%	-5.60%	-10.60%	104.11%	13.50%	-26.49%	-60.38%	144.61%	-55.06%	42.70%	-36.18%
EBIT Q/Q Growth	-24.72%	-4.15%	-14.19%	166.18%	12.56%	-41.96%	-65.28%	181.43%	-60.24%	50.03%	-39.71%
NOPAT Q/Q Growth	-9.27%	-4.43%	-23.73%	244.63%	-2.38%	-53.60%	-61.17%	155.23%	-57.32%	46.80%	-41.97%
Net Income Q/Q Growth	-16.73%	-4.21%	-18.28%	201.21%	7.06%	-40.64%	-67.09%	124.38%	-53.69%	62.78%	-42.31%
EPS Q/Q Growth	-17.65%	0.00%	-19.05%	200.00%	16.67%	-45.45%	-66.67%	120.00%	-53.13%	68.42%	-44.12%
Operating Cash Flow Q/Q Growth	-21.21%	-8.65%	102.68%	103.50%	-5.85%	-64.68%	37.44%	8.33%	-58.42%	-20.67%	89.34%
Free Cash Flow Firm Q/Q Growth	-3.88%	107.80%	-7.94%	15.76%	4.17%	-569.97%	-644.76%	156.61%	-51.61%	63.75%	54.44%
Invested Capital Q/Q Growth	0.29%	-3.09%	0.89%	2.02%	0.44%	44.41%	-0.78%	7.57%	3.13%	2.20%	-5.04%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	66.81%	68.73%	67.90%	69.62%	67.33%	68.67%	72.39%	74.09%	71.47%	70.82%	72.63%
EBITDA Margin	14.62%	17.13%	17.76%	19.49%	10.84%	10.23%	13.88%	28.50%	14.05%	26.26%	21.02%
Operating Margin	12.08%	13.43%	13.45%	16.07%	6.74%	6.47%	15.53%	26.88%	11.02%	22.69%	19.09%
EBIT Margin	11.02%	13.77%	14.06%	16.07%	6.85%	6.53%	11.21%	26.26%	11.25%	23.77%	18.09%
Profit (Net Income) Margin	10.93%	12.34%	12.61%	15.13%	5.70%	5.71%	9.59%	23.70%	12.74%	23.10%	16.21%
Tax Burden Percent	84.91%	79.18%	80.95%	87.12%	68.44%	78.23%	70.05%	84.80%	97.71%	93.38%	86.36%
Interest Burden Percent	116.76%	113.20%	110.79%	108.10%	121.60%	111.84%	122.12%	106.43%	115.85%	104.09%	103.73%
Effective Tax Rate	15.09%	20.82%	19.05%	12.88%	31.56%	21.77%	29.95%	15.20%	2.29%	6.62%	13.64%
Return on Invested Capital (ROIC)	10.11%	10.46%	11.97%	14.78%	5.09%	5.61%	15.77%	32.55%	17.06%	38.53%	30.89%
ROIC Less NNEP Spread (ROIC-NNEP)	9.84%	9.79%	11.42%	14.38%	4.76%	5.43%	16.08%	32.28%	16.58%	38.01%	30.95%
Return on Net Nonoperating Assets (RNNOA)	-3.59%	-3.77%	-5.43%	-6.68%	-2.27%	-2.64%	-9.29%	-18.22%	-9.68%	-23.34%	-19.36%
Return on Equity (ROE)	6.53%	6.69%	6.54%	8.09%	2.82%	2.97%	6.48%	14.33%	7.38%	15.18%	11.52%
Cash Return on Invested Capital (CROIC)	11.28%	9.82%	-29.75%	-28.58%	-30.44%	-31.07%	13.01%	18.65%	22.11%	27.15%	27.59%
Operating Return on Assets (OROA)	5.14%	6.28%	6.11%	6.78%	2.91%	2.75%	5.07%	11.90%	5.32%	12.07%	9.26%
Return on Assets (ROA)	5.09%	5.63%	5.48%	6.38%	2.42%	2.41%	4.34%	10.74%	6.03%	11.73%	8.30%
Return on Common Equity (ROCE)	6.53%	6.69%	6.54%	8.09%	2.82%	2.97%	6.48%	14.33%	7.38%	15.18%	11.52%
Return on Equity Simple (ROE_SIMPLE)	8.15%	0.00%	5.68%	5.20%	6.69%	0.00%	10.57%	11.64%	12.02%	0.00%	15.39%
Net Operating Profit after Tax (NOPAT)	22	24	26	34	9.72	9.96	21	55	22	51	35
NOPAT Margin	10.26%	10.63%	10.88%	14.00%	4.61%	5.06%	10.88%	22.79%	10.77%	21.19%	16.49%
Net Nonoperating Expense Percent (NNEP)	0.27%	0.68%	0.56%	0.39%	0.33%	0.18%	-0.31%	0.27%	0.48%	0.52%	-0.07%
Return On Investment Capital (ROIC_SIMPLE)	1.53%	1.61%	-	-	-	0.66%	-	-	-	3.53%	-
Cost of Revenue to Revenue	33.19%	31.27%	32.10%	30.38%	32.67%	31.33%	27.61%	25.91%	28.53%	29.18%	27.37%
SG&A Expenses to Revenue	38.65%	41.14%	39.46%	38.94%	42.99%	45.95%	41.73%	34.40%	41.29%	31.72%	35.96%
R&D to Revenue	16.07%	14.17%	15.00%	14.61%	17.60%	17.64%	16.52%	13.85%	19.16%	15.51%	16.20%
Operating Expenses to Revenue	54.73%	55.30%	54.46%	53.55%	60.60%	62.19%	56.85%	47.22%	60.45%	48.12%	53.53%
Earnings before Interest and Taxes (EBIT)	24	32	33	38	14	13	22	64	23	57	38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	32	39	42	47	23	20	27	69	28	63	44
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.53	4.05	4.41	5.32	4.89	4.74	4.88	6.47	5.85	5.59	5.11
Price to Tangible Book Value (P/TBV)	5.28	5.90	6.44	7.80	7.29	7.14	5.86	7.80	7.09	6.79	6.21
Price to Revenue (P/Rev)	5.54	6.73	7.83	9.49	8.59	8.52	8.24	10.73	9.15	7.99	7.02
Price to Earnings (P/E)	43.29	57.93	77.55	102.21	73.03	62.99	46.13	55.59	48.68	37.28	33.18
Dividend Yield	1.03%	0.85%	0.75%	0.63%	0.69%	0.69%	0.66%	0.50%	0.55%	0.57%	0.64%
Earnings Yield	2.31%	1.73%	1.29%	0.98%	1.37%	1.59%	2.17%	1.80%	2.05%	2.68%	3.01%
Enterprise Value to Invested Capital (EV/IC)	4.91	5.98	6.56	7.84	7.21	7.06	9.97	13.50	12.64	12.29	10.98
Enterprise Value to Revenue (EV/Rev)	4.98	6.08	7.15	8.83	7.93	7.83	7.28	9.80	8.24	7.14	6.21
Enterprise Value to EBITDA (EV/EBITDA)	28.79	36.96	47.98	63.74	48.18	45.25	34.17	42.83	37.30	26.74	23.38
Enterprise Value to EBIT (EV/EBIT)	36.14	47.34	63.80	84.88	59.43	54.07	38.78	48.31	42.23	29.43	25.78
Enterprise Value to NOPAT (EV/NOPAT)	43.47	59.88	80.28	99.55	69.61	59.95	42.63	53.80	45.65	33.93	29.48
Enterprise Value to Operating Cash Flow (EV/OCF)	26.06	37.32	56.16	76.93	67.87	58.06	38.93	42.24	34.40	29.50	27.01
Enterprise Value to Free Cash Flow (EV/FCFF)	43.59	60.99	0.00	0.00	0.00	0.00	81.13	75.08	59.03	47.79	42.15
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.36	-0.39	-0.48	-0.46	-0.48	-0.49	-0.58	-0.56	-0.58	-0.61	-0.63
Leverage Ratio	1.34	1.33	1.33	1.34	1.36	1.35	1.35	1.37	1.39	1.38	1.37
Compound Leverage Factor	1.57	1.50	1.47	1.45	1.65	1.51	1.65	1.46	1.61	1.44	1.42
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	7.34	8.89	9.48	10.82	9.41	9.45	9.95	12.36	10.80	10.59	9.70
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.14	3.62	3.94	4.03	3.52	4.47	4.99	3.98	3.38	3.82	4.88
Quick Ratio	1.98	2.32	2.62	2.67	2.23	2.95	3.80	2.88	2.46	2.81	3.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	22	23	-291	-270	-320	-334	-50	9.16	-16	-11	-29
Operating Cash Flow to CapEx	1,619.43%	2,479.69%	1,279.18%	615.59%	335.95%	206.57%	700.65%	635.09%	500.33%	1,631.14%	1,919.12%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.46	0.44	0.42	0.43	0.42	0.45	0.45	0.47	0.51	0.51
Accounts Receivable Turnover	6.03	6.96	6.03	5.42	5.89	6.86	7.64	5.51	6.10	7.68	8.58
Inventory Turnover	1.81	1.81	1.93	1.82	1.66	1.66	2.02	2.23	1.99	2.41	2.99
Fixed Asset Turnover	9.19	8.95	9.47	9.14	9.14	9.03	10.84	11.08	11.62	12.80	12.93
Accounts Payable Turnover	8.24	9.70	10.50	10.58	9.11	9.73	10.80	10.65	7.33	7.99	11.56
Days Sales Outstanding (DSO)	60.57	52.48	60.50	67.31	62.00	53.20	47.80	66.19	59.88	47.51	42.53
Days Inventory Outstanding (DIO)	202.16	202.15	189.46	200.80	219.50	219.93	180.91	163.90	183.21	151.29	122.18
Days Payable Outstanding (DPO)	44.29	37.61	34.75	34.51	40.07	37.50	33.79	34.27	49.78	45.69	31.57
Cash Conversion Cycle (CCC)	218.43	217.02	215.21	233.59	241.43	235.63	194.92	195.82	193.31	153.11	133.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	933	930	960	951	933	928	643	648	602	584	572
Invested Capital Turnover	0.99	0.98	1.10	1.06	1.10	1.11	1.45	1.43	1.58	1.82	1.87
Increase / (Decrease) in Invested Capital	0.30	1.68	317	303	330	344	71	46	38	61	64
Enterprise Value (EV)	4,585	5,564	6,299	7,456	6,720	6,556	6,412	8,750	7,617	7,182	6,276
Market Capitalization	5,098	6,151	6,906	8,011	7,276	7,132	7,258	9,583	8,461	8,036	7,093
Book Value per Share	$8.51	$8.85	$9.14	$8.78	$8.67	$8.74	$8.64	$8.58	$8.38	$8.32	$8.01
Tangible Book Value per Share	$5.68	$6.07	$6.26	$5.98	$5.81	$5.80	$7.18	$7.12	$6.91	$6.84	$6.59
Total Capital	1,446	1,518	1,567	1,507	1,489	1,505	1,489	1,480	1,446	1,438	1,389
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-513	-587	-607	-555	-557	-576	-846	-832	-844	-854	-818
Capital Expenditures (CapEx)	2.50	2.07	4.40	4.51	4.06	7.02	5.86	4.70	5.51	4.06	4.35
Debt-free, Cash-free Net Working Capital (DFCFNWC)	193	198	213	223	195	195	165	169	127	130	152
Debt-free Net Working Capital (DFNWC)	394	444	501	512	473	527	677	538	508	530	626
Net Working Capital (NWC)	394	444	501	512	473	527	677	538	508	530	626
Net Nonoperating Expense (NNE)	-1.45	-3.93	-4.04	-2.71	-2.30	-1.27	2.55	-2.21	-3.96	-4.57	0.59
Net Nonoperating Obligations (NNO)	-513	-587	-607	-555	-557	-576	-846	-832	-844	-854	-818
Total Depreciation and Amortization (D&A)	7.77	7.73	8.69	8.18	8.40	7.29	5.27	5.43	5.63	5.97	6.13
Debt-free, Cash-free Net Working Capital to Revenue	21.01%	21.64%	24.22%	26.44%	23.04%	23.29%	18.70%	18.93%	13.77%	12.91%	15.01%
Debt-free Net Working Capital to Revenue	42.81%	48.55%	56.87%	60.69%	55.88%	62.94%	76.94%	60.26%	54.95%	52.68%	61.95%
Net Working Capital to Revenue	42.81%	48.55%	56.87%	60.69%	55.88%	62.94%	76.94%	60.26%	54.95%	52.68%	61.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.14	$0.17	$0.17	$0.21	$0.07	$0.07	$0.11	$0.33	$0.15	$0.31	$0.00
Adjusted Weighted Average Basic Shares Outstanding	169.27M	171.44M	171.52M	171.57M	171.69M	172.25M	172.17M	172.43M	172.62M	173.41M	173.26M
Adjusted Diluted Earnings per Share	$0.14	$0.17	$0.17	$0.21	$0.07	$0.06	$0.11	$0.33	$0.15	$0.32	$0.19
Adjusted Weighted Average Diluted Shares Outstanding	170.39M	172.61M	172.75M	172.73M	172.59M	173.40M	173.35M	173.62M	173.90M	174.87M	174.33M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	167.86M	169.87M	171.52M	171.50M	171.66M	343.27M	172.14M	172.29M	172.60M	345.07M	172.93M
Normalized Net Operating Profit after Tax (NOPAT)	22	24	26	34	9.72	9.96	21	55	22	51	35
Normalized NOPAT Margin	10.26%	10.63%	10.88%	14.00%	4.61%	5.06%	10.88%	22.79%	10.77%	21.19%	16.49%
Pre Tax Income Margin	12.87%	15.59%	15.57%	17.37%	8.33%	7.30%	13.69%	27.95%	13.03%	24.74%	18.77%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	45.00%	49.29%	57.82%	64.65%	50.06%	43.34%	30.70%	27.56%	26.87%	21.31%	21.19%
Augmented Payout Ratio	180.86%	112.47%	107.22%	129.10%	115.24%	113.81%	85.09%	85.08%	83.31%	116.10%	157.68%

Frequently Asked Questions About Cognex's Financials

When does Cognex's fiscal year end?

According to the most recent income statement we have on file, Cognex's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Cognex's net income changed over the last 9 years?

Cognex's net income were at $106.17 million at the end of 2024, a 6.2% decrease from 2023, and a 43.2% decrease since 2015. View Cognex's forecast to see where analysts expect Cognex to go next.

What is Cognex's operating income?

Cognex's total operating income in 2024 was $115.07 million, based on the following breakdown:

Total Gross Profit: $625.79 million
Total Operating Expenses: $510.73 million

How has Cognex revenue changed over the last 9 years?

Over the last 9 years, Cognex's total revenue changed from $450.56 million in 2015 to $914.52 million in 2024, a change of 103.0%.

How much debt does Cognex have?

Cognex's total liabilities were at $475.35 million at the end of 2024, a 7.4% decrease from 2023, and a 665.6% increase since 2015.

How much cash does Cognex have?

In the past 9 years, Cognex's cash and equivalents has ranged from $51.98 million in 2015 to $269.07 million in 2020, and is currently $186.09 million as of their latest financial filing in 2024.

How has Cognex's book value per share changed over the last 9 years?

Over the last 9 years, Cognex's book value per share changed from 9.73 in 2015 to 8.85 in 2024, a change of -9.1%.

Related Companies

This page (NASDAQ:CGNX) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cognex (CGNX) Financials

Frequently Asked Questions About Cognex's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cognex (CGNX) Financials

Annual Income Statements for Cognex

Quarterly Income Statements for Cognex

Annual Cash Flow Statements for Cognex

Quarterly Cash Flow Statements for Cognex

Annual Balance Sheets for Cognex

Quarterly Balance Sheets for Cognex

Annual Metrics And Ratios for Cognex

Quarterly Metrics And Ratios for Cognex

Frequently Asked Questions About Cognex's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools